| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/11/2008 | US20080220100 Fermented panax notoginseng solution with anti-cancer effects and manufacture method thereof |
| 09/11/2008 | US20080220093 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 09/11/2008 | US20080220092 Overcoming active agent tolerance, which may be experienced from continuous administration, improve patient compliance, and in some cases reducing the amount of drug needed per dose due to advantages of biosynchronization |
| 09/11/2008 | US20080220090 selectively exploit chemical variations between normal cells and cancer cells to inhibit or prevent the proliferation of cancerous cells; biologically acceptable copper compound |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220073 The Treatment of Respiratory Diseases |
| 09/11/2008 | US20080220057 Therapeutic compounds and methods of use |
| 09/11/2008 | US20080220027 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 09/11/2008 | US20080220025 grafting a mixture of alloactivated lymphocytes in a compatible drug excipient, in or around a tumor site, to elicite an antitumor immunology response; cellular immunology and cancer therapy |
| 09/11/2008 | US20080220011 Flagellin/tumor antigen fusion for use in induction of immune response to cancer antigen; tissue targeted therapy; antitumor agents |
| 09/11/2008 | US20080219997 Her-2 binding antagonists |
| 09/11/2008 | US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/11/2008 | US20080219993 RalGDS related (RGR) protein specific immunoglobulin for treatment and prevention of cell proliferative disorders |
| 09/11/2008 | US20080219992 Pancreatic protein for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219985 Prok2 antagonists and methods of use |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219981 Solid cancer antigenic polypeptide for use in designing and identifying modulators for prevention and treatment of tumorous masses |
| 09/11/2008 | US20080219980 Bi-Specific Complexes for Targeting Cells Involved in Allergic-Type Reactions, Compositions and Uses Thereof |
| 09/11/2008 | US20080219977 Combinations Comprising Gemcitabine and Tyrosine Kinase Inhibitors for the Treatment of Pancreatic Cancer |
| 09/11/2008 | US20080219975 Vegfr3 inhibitors |
| 09/11/2008 | US20080219968 Son of sevenless homolog 1 (SOS1) suppressive agent for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219958 Treating neuroblastoma in mammals via exposure to tumor antigen pulsed antigen-presenting cells; tissue targeted therapy; immunotherapy |
| 09/11/2008 | US20080219953 Cosmid dna constructs and methods of making and using same |
| 09/11/2008 | US20080219949 Methods for treating brain cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | US20080219923 Method and Kit for the Production of Particles Labelled with Rhenium-188 |
| 09/11/2008 | US20080219919 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/11/2008 | US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates |
| 09/11/2008 | DE102007011702A1 Aptamer-basierte Reagenzien Aptamer-based reagents |
| 09/11/2008 | DE102006050091A1 Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients |
| 09/10/2008 | EP1967856A2 Tumour marker proteins and uses thereof |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | EP1967520A2 Production of polyketides and other natural products |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1967516A1 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative diseases |
| 09/10/2008 | EP1967209A1 Therapeutic agent for prostate cancer |
| 09/10/2008 | EP1967193A1 Enhancement of anticancer therapy by flavonoids |
| 09/10/2008 | EP1967189A1 Methods for treating resistant or refractory tumors |
| 09/10/2008 | EP1967188A1 Pharmaceutical preparation of aqueous solution containing platinum complex |
| 09/10/2008 | EP1967183A1 Controlled release solid preparation |
| 09/10/2008 | EP1966245A1 Anti-cd19 antibodies with reduced immunogenicity |
| 09/10/2008 | EP1966244A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 09/10/2008 | EP1966242A1 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| 09/10/2008 | EP1966222A2 Pyrazolothiazole protein kinase modulators |
| 09/10/2008 | EP1966213A1 Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 09/10/2008 | EP1966212A1 Diazepinones |
| 09/10/2008 | EP1966211A1 Triazole derivatives |
| 09/10/2008 | EP1966210A2 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 09/10/2008 | EP1966207A2 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/10/2008 | EP1966202A1 Heteroaryl substituted pyrroloý2,3-b¨pyridines and pyrroloý2,3-b¨pyrimidines as janus kinase inhibitors |
| 09/10/2008 | EP1966200A1 Heterocyclic janus kinase 3 inhibitors |
| 09/10/2008 | EP1966192A2 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/10/2008 | EP1966190A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 09/10/2008 | EP1966189A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 09/10/2008 | EP1966183A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/10/2008 | EP1966174A1 Chemical compounds |
| 09/10/2008 | EP1966172A1 Thiazoles for the treatment of proliferative disorders |
| 09/10/2008 | EP1966166A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS |
| 09/10/2008 | EP1966156A2 New compounds iii |
| 09/10/2008 | EP1966155A1 Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer |
| 09/10/2008 | EP1966151A1 Polycyclic indazole derivatives that are erk inhibitors |
| 09/10/2008 | EP1965865A2 Combination of an iap-inhibitor and a taxane7 |
| 09/10/2008 | EP1965824A2 Metabolite derivatives of the hdac inhibitor fk228 |
| 09/10/2008 | EP1965819A2 Scutellaria barbata extract for the treatment of cancer |
| 09/10/2008 | EP1965801A2 Combination of azd2171 and pemetrexed |
| 09/10/2008 | EP1965790A2 Metabolites of wortmannin analogs and methods of using the same |
| 09/10/2008 | EP1965784A1 Combination comprising combretastatin and anticancer agents |
| 09/10/2008 | EP1771181B1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 09/10/2008 | EP1677811B1 Medicament on the basis of honey, preparation and use thereof |
| 09/10/2008 | EP1651247B1 Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin |
| 09/10/2008 | EP1633883B1 Method for assaying lkb1 phosphorylation activity |
| 09/10/2008 | EP1597240B1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 09/10/2008 | EP1558620B1 Ruthenium anticancer complexes |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 09/10/2008 | EP1437349B9 Substituted isoxazoles and the use thereof as antibiotics |
| 09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 09/10/2008 | EP1303284B1 Compositions and methods for the treatment of skin damage |
| 09/10/2008 | EP1301474B1 Tyrosine derivatives as phosphatase inhibitors |
| 09/10/2008 | EP1289570B1 Liposomal encapsulation of alpha-emitters and uses thereof |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | EP1237910B1 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 09/10/2008 | EP1200124B1 Erythropoietin-immunoglobulin fusion proteins |
| 09/10/2008 | EP1159967B1 Tumor vaccines |
| 09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
| 09/10/2008 | EP1062232B1 Molecules that home to various selected organs or tissues |
| 09/10/2008 | EP1060247B1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 09/10/2008 | EP0944389B1 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| 09/10/2008 | CN101263159A Compositions and methods for the diagnosis and treatment of tumor |
| 09/10/2008 | CN101263145A 4-amino-thieno[3,2-C] pyridine-7-carboxylic acid derivatives |
| 09/10/2008 | CN101263143A Crystalline forms of a pyrrolotriazine compound |
| 09/10/2008 | CN101263142A RAF inhibitor compounds and methods of use thereof |
| 09/10/2008 | CN101263120A 4,5-dihydro-1h-pyrazole derivatives, their preparation and use as medicaments |